日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Long non-coding RNA STMN1P2 promotes breast cancer doxorubicin resistance by inhibiting pyroptosis through the hnRNPU-EZH2-TARF6-MALT1-caspase-1 pathway.

长链非编码RNA STMN1P2通过hnRNPU-EZH2-TARF6-MALT1-caspase-1通路抑制细胞焦亡,从而促进乳腺癌对阿霉素的耐药性。

Jin You-Ping, Xu Bu-Jie, Zhang Xiu-Fen, Wang Xue, Wang Li, Li Lu-Ying, Chen Shu-Yi, Zhu Ping, Zhi Xiu-Ling, Lv Lei, Wang Chao-Fu, Wang Zheng-Lin, Sun Yang-Bai, Zhou Ping

Mechanistic Insights Into Immune Cell Dysregulation Mediated by Novel Heterozygous Variants in CARD11 and MALT1.

CARD11 和 MALT1 中新型杂合变异介导的免疫细胞失调的机制见解。

Li Rui, Sun Xiaochen, Bao Wei, Yu Haolan, Dan YuQing, Wu Chunmei, Ma Yan, Yin Hanlin, Lin Wanyi, Lu Liangjing, Fu Qiong, Yang Chenghua

MALT1 Knockdown Alleviates Multiorgan Injury and Inflammation Through Inhibiting TAK1/NF-κB Signaling Pathway-Mediated T-Helper 1 and 17 Differentiations in LPS-induced Inflammation

MALT1敲低通过抑制TAK1/NF-κB信号通路介导的T辅助细胞1和17分化来减轻LPS诱导的炎症中的多器官损伤和炎症

Huang, Qinghe; Luo, Yan; Chen, Qinggui; Cui, Yan

Novel Compounds as MALT1 Inhibitors for Treating Cancer

新型化合物作为MALT1抑制剂用于治疗癌症

Sabnis, Ram W

Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects

MALT1在肿瘤治疗中的靶向作用:机制、抑制剂研发及临床前景

Cao, Xintao; Wang, Peixia; Ji, Yuan; Sun, Yongliang; Zhang, Dejiu

MALT1 inhibition by MI‑2 suppresses epithelial‑to‑mesenchymal transition and fibrosis by inactivating the NF‑κB pathway in high glucose‑treated HK‑2 cells

MI-2通过抑制MALT1来抑制高糖处理的HK-2细胞中的NF-κB通路,从而抑制上皮间质转化和纤维化。

Lan, Yating; Ma, Jian; Chen, Huijun; Lan, Chaohong; Zhao, Na

Decoding Allosteric Inhibition in MALT1: The Hidden Role of Conformational Plasticity in Metastable States via Biased MD and Deep Learning

利用偏向分子动力学和深度学习解码MALT1中的变构抑制:构象可塑性在亚稳态中的隐藏作用

Santos, Rodrigo M; Santos, Taináh M R; Ramalho, Teodorico C

A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers

一项评估 MALT1 抑制剂 SGR-1505 在健康志愿者中的安全性、耐受性、药代动力学和药效学的 1 期剂量递增、食物影响和药物相互作用研究

Gupta, Vipul K; Yoo, Brian; Weiss, Daniel; Basile, Frank G; Schuck, Edgar; Rubino, Christopher M; Zhang, Sen; Maxwell, Stephen E; Zheng, Wenxin; Tan, Joanne B L; Stenehjem, David; Watkins, Paul B; Dugan, Margaret; Yin, Wu; Wright, D Hamish; Akinsanya, Karen; Lickliter, Jason

Correction to: TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways

更正:TIFA通过MALT1依赖性和非依赖性信号通路抑制肝细胞癌进展

Shen, Wenzhi; Du, Renle; Li, Jun; Luo, Xiaohe; Zhao, Shuangtao; Chang, Antao; Zhou, Wei; Gao, Ruifang; Luo, Dehong; Wang, Juan; Hao, Na; Liu, Yanhua; Chen, Yanan; Luo, Yunping; Sun, Peiqing; Yang, Shengyong; Luo, Na; Xiang, Rong

The CARD14sh-BCL10-MALT1 complex regulates MAVS-mediated antiviral response in keratinocytes

CARD14sh-BCL10-MALT1复合物调节角质形成细胞中MAVS介导的抗病毒反应

Zerillo, Lucrezia; Zotti, Tiziana; Tutela, Angelapia; Madera, Jessica Raffaella; Grasso, Gabriella; Vito, Pasquale; Stilo, Romania